Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Relapsing Fever | 1 | 2020 | 19 | 0.770 |
Why?
|
| Ticks | 1 | 2020 | 70 | 0.760 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2019 | 1634 | 0.750 |
Why?
|
| Deoxycytidine | 3 | 2018 | 825 | 0.600 |
Why?
|
| Plasma Gases | 1 | 2017 | 10 | 0.590 |
Why?
|
| Mouth Neoplasms | 3 | 2014 | 601 | 0.480 |
Why?
|
| Exosomes | 1 | 2018 | 413 | 0.460 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 5169 | 0.460 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 561 | 0.450 |
Why?
|
| Pancreatic Neoplasms | 5 | 2018 | 5257 | 0.450 |
Why?
|
| Carcinoma, Adenoid Cystic | 4 | 2015 | 252 | 0.420 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2015 | 477 | 0.410 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 6352 | 0.350 |
Why?
|
| MicroRNAs | 2 | 2018 | 3747 | 0.250 |
Why?
|
| Neck Dissection | 3 | 2014 | 197 | 0.240 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3703 | 0.220 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2019 | 640 | 0.210 |
Why?
|
| Head and Neck Neoplasms | 4 | 2014 | 2732 | 0.180 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2020 | 102 | 0.180 |
Why?
|
| Collagenases | 1 | 2019 | 228 | 0.170 |
Why?
|
| Doxycycline | 1 | 2020 | 326 | 0.170 |
Why?
|
| Leukocyte Elastase | 1 | 2019 | 113 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2015 | 4033 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2017 | 220 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 553 | 0.150 |
Why?
|
| Macrophages, Peritoneal | 1 | 2018 | 251 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5670 | 0.150 |
Why?
|
| Tumor Microenvironment | 3 | 2019 | 3584 | 0.140 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 16687 | 0.140 |
Why?
|
| Ribonucleotide Reductases | 1 | 2015 | 77 | 0.130 |
Why?
|
| Biomedical Engineering | 1 | 2017 | 296 | 0.130 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2014 | 65 | 0.130 |
Why?
|
| Cellulose, Oxidized | 1 | 2013 | 12 | 0.120 |
Why?
|
| Nomograms | 1 | 2015 | 228 | 0.120 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2014 | 123 | 0.110 |
Why?
|
| Nervous System | 1 | 2017 | 554 | 0.110 |
Why?
|
| Status Epilepticus | 1 | 2019 | 444 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2014 | 276 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2018 | 1224 | 0.110 |
Why?
|
| Hemostasis, Surgical | 1 | 2013 | 128 | 0.110 |
Why?
|
| Quality of Life | 1 | 2014 | 12805 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13668 | 0.110 |
Why?
|
| Lymph Nodes | 2 | 2014 | 3469 | 0.100 |
Why?
|
| Methotrexate | 1 | 2019 | 1720 | 0.100 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18027 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 252 | 0.100 |
Why?
|
| Fever | 1 | 2019 | 1614 | 0.100 |
Why?
|
| Thyroidectomy | 2 | 2014 | 879 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 21824 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2186 | 0.100 |
Why?
|
| Neutrophils | 2 | 2023 | 3717 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1401 | 0.090 |
Why?
|
| Hemostatics | 1 | 2013 | 229 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2014 | 512 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2014 | 441 | 0.090 |
Why?
|
| Macrophages | 2 | 2017 | 5657 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3614 | 0.090 |
Why?
|
| Neck | 1 | 2014 | 696 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 412 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2019 | 1564 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2014 | 720 | 0.090 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 661 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1344 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2018 | 4217 | 0.080 |
Why?
|
| Equipment Design | 1 | 2017 | 3582 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2019 | 1905 | 0.080 |
Why?
|
| Mice | 8 | 2019 | 81178 | 0.080 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 11007 | 0.080 |
Why?
|
| Animals | 9 | 2020 | 168788 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1270 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9230 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2213 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14556 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 1955 | 0.070 |
Why?
|
| Aged, 80 and over | 9 | 2015 | 57768 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39045 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3800 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 1587 | 0.060 |
Why?
|
| Prognosis | 5 | 2014 | 29050 | 0.060 |
Why?
|
| Disease Progression | 2 | 2017 | 13280 | 0.060 |
Why?
|
| Apoptosis | 2 | 2017 | 9728 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10250 | 0.050 |
Why?
|
| Israel | 2 | 2015 | 796 | 0.050 |
Why?
|
| Humans | 23 | 2023 | 744220 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3328 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.050 |
Why?
|
| Young Adult | 7 | 2015 | 56436 | 0.050 |
Why?
|
| Algorithms | 2 | 2019 | 13885 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 2281 | 0.050 |
Why?
|
| Glioma | 1 | 2014 | 3401 | 0.040 |
Why?
|
| Survival Rate | 4 | 2014 | 12781 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2023 | 973 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8426 | 0.040 |
Why?
|
| British Columbia | 1 | 2019 | 244 | 0.040 |
Why?
|
| Middle Aged | 11 | 2019 | 213367 | 0.040 |
Why?
|
| International Cooperation | 2 | 2015 | 1421 | 0.040 |
Why?
|
| Adult | 11 | 2019 | 214035 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 590 | 0.040 |
Why?
|
| Aged | 9 | 2015 | 163253 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 1504 | 0.040 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 1996 | 49 | 0.040 |
Why?
|
| Female | 13 | 2019 | 380197 | 0.030 |
Why?
|
| Peroxidase | 1 | 2019 | 611 | 0.030 |
Why?
|
| Liposomes | 1 | 2019 | 758 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 2914 | 0.030 |
Why?
|
| Male | 12 | 2019 | 350027 | 0.030 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2014 | 13 | 0.030 |
Why?
|
| Thyroid Cartilage | 1 | 2014 | 42 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1269 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2019 | 77426 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 6893 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21672 | 0.030 |
Why?
|
| Adolescent | 6 | 2019 | 85759 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 8860 | 0.030 |
Why?
|
| Abdominal Injuries | 1 | 1996 | 352 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 4841 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 534 | 0.030 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 110 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2019 | 881 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2013 | 158 | 0.030 |
Why?
|
| International Agencies | 1 | 2013 | 240 | 0.030 |
Why?
|
| Pancreas | 1 | 2019 | 1686 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 2029 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 453 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2015 | 23404 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2019 | 1707 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 20817 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 1741 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15070 | 0.020 |
Why?
|
| ROC Curve | 1 | 2019 | 3527 | 0.020 |
Why?
|
| Collagen | 1 | 2019 | 2689 | 0.020 |
Why?
|
| Mouth | 1 | 2013 | 374 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12244 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2013 | 402 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8321 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1996 | 794 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1590 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 2416 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 19907 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5076 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2030 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 1094 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1119 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6313 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 1770 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18367 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2619 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2525 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11368 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10182 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3557 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6461 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 4216 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8437 | 0.010 |
Why?
|
| Child | 2 | 2023 | 77679 | 0.010 |
Why?
|
| Time Factors | 2 | 2015 | 40063 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6535 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5216 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 7022 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10396 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10949 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10480 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6308 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2015 | 63119 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7659 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12961 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 72280 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13990 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 40992 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 20945 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23337 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1996 | 504 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 53280 | 0.010 |
Why?
|
| Liver | 1 | 1996 | 7472 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20123 | 0.000 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_